Filtered By:
Condition: SARS
Vaccination: Vaccines
This page shows you your search results in order of date.
Order by Relevance | Date
Total 671 results found since Jan 2013.
Chronic Spontaneous Urticaria Following mRNA COVID-19 Booster Vaccination at a Military Academy
We present a retrospective case series of CSU following Moderna COVID-19 booster vaccinations at the US Naval Academy (USNA). Demographics, clinical features, and impact on readiness were evaluated. Forty-nine students from the USNA were evaluated for urticaria after their third COVID-19 booster vaccination. Seventeen individuals were diagnosed with CSU. The median age was 20 years and predominantly male; the median time interval between vaccination and the onset of urticaria was 11 days. Out of 13 referred to Allergy, 7 patients had CU index performed and 2 were positive. Four patients received a second booster vaccinatio...
Source: Military Medicine - September 19, 2023 Category: International Medicine & Public Health Authors: Mechelle A Miller Emily R Raffetto Rachel U Lee Source Type: research
Immune response after SARS-CoV-2 vaccination in patients with inflammatory immune-mediated diseases receiving immunosuppressive treatment
Real world data on the response to the SARS-CoV-2 vaccine in patients with immunomediated diseases (IMIDs) treated with immunesuppressants is of great interest because vaccine response may be impaired. The mai...
Source: Allergy, Asthma and Clinical Immunology - August 19, 2023 Category: Allergy & Immunology Authors: Chamaida Plasencia-Rodr íguez, Ana Martínez-Feito, Marta Hernández, Lucia Del Pino-Molina, Marta Novella-Navarro, Yolanda Serrano, Miguel González-Muñoz, Diana Peiteado, Gema Bonilla, Irene Monjo, Laura Nuño, Carolina Tornero, Eduardo López-Granado Tags: Research Source Type: research
Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance
CONCLUSION: We demonstrate impaired immunity following SARS-CoV-2 mRNA immunization in a murine model of comorbid T2DM and obesity, supporting the need for further research into the basis for impaired anti-SARS-CoV-2 immunity in T2DM and investigation of novel approaches to enhance vaccine immunogenicity among those with metabolic diseases.PMID:37595760 | DOI:10.1016/j.jaci.2023.06.031
Source: Clinical Lung Cancer - August 18, 2023 Category: Cancer & Oncology Authors: Timothy R O'Meara Etsuro Nanishi Marisa E McGrath Soumik Barman Danica Dong Carly Dillen Manisha Menon Hyuk-Soo Seo Sirano Dhe-Paganon Robert K Ernst Ofer Levy Matthew B Frieman David J Dowling Source Type: research
Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistance.
Obesity and type 2 diabetes impair SARS-CoV-2 mRNA vaccine efficacy in a murine model.
Source: Journal of Allergy and Clinical Immunology - August 16, 2023 Category: Allergy & Immunology Authors: Timothy R. O ’Meara, Etsuro Nanishi, Marisa E. McGrath, Soumik Barman, Danica Dong, Carly Dillen, Manisha Menon, Hyuk-Soo Seo, Sirano Dhe-Paganon, Robert K. Ernst, Ofer Levy, Matthew B. Frieman, David J. Dowling Source Type: research
Post Omicron, Most Canadians Have Hybrid Immunity Post Omicron, Most Canadians Have Hybrid Immunity
Most Canadians now have hybrid immunity against SARS-CoV-2 through a combination of infection and vaccination, but certain groups remain vulnerable.Medscape Medical News
Source: Medscape Allergy Headlines - August 14, 2023 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT
ConclusionsMost IBD patients showed a sufficient immune response to COVID-19 vaccination regardless of clinical factors. Assessment of changes over time is essential to optimize COVID-19 vaccination, especially in persistently low responders.Graphical abstract
Source: Journal of Gastroenterology - August 10, 2023 Category: Gastroenterology Source Type: research
The U.S. Scientist At the Heart of COVID-19 Lab Leak Conspiracies Is Still Trying to Save the World From the Next Pandemic
Ralph Baric stepped onto the auditorium stage at the University of North Carolina, Chapel Hill, and looked out at the sparse audience that had come to hear him speak. On the large projector screen hanging behind him, the following words appeared: How Bad the Next Pandemic Could Be, What Might It Look Like, and Will We be Ready. The date was May 29, 2018.
“Well, I have to admit I’m a little worried about giving this talk,” Baric said. “The reason is being labelled a harbinger of doom.” The screen shifted, and images of the four horsemen of the apocalypse—Death, Famine, War, and Plague&mda...
Source: TIME: Health - July 11, 2023 Category: Consumer Health News Authors: Dan Werb Tags: Uncategorized COVID-19 feature freelance Source Type: news
Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana
Conclusion
The results of our study indicate a high incidence of non-serious AEFI and the rare occurrence of serious AEFI after COVISHIELD vaccination in healthcare workers. The rate of AEFI was higher after the first dose than after the second dose. Sex, age, previous SARS-CoV-2 infection, allergies and comorbidity were not significantly associated with the onset and duration of AEFI.
Source: BMJ Open - June 28, 2023 Category: General Medicine Authors: Marfoh, K., Samba, A., Okyere, E., Acheampong, F., Owusu, E., Darko, D. N. A., Zakariah, J., Mensa, H., Aidoo, E., Mohammed, Y. Tags: Open access, Immunology (including allergy), COVID-19 Source Type: research
COVID-19, Coronavirus Vaccines, and Possible Association with Lipsch ütz Vulvar Ulcer: A Systematic Review
In conclusion, COVID-19 and immunization against SARS-CoV-2 add to Epstein-Barr virus as plausible triggers of Lipschütz genital ulcer.
Source: Clinical Reviews in Allergy and Immunology - June 26, 2023 Category: Allergy & Immunology Source Type: research
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients
Vaccine. 2023 Jun 15:S0264-410X(23)00714-4. doi: 10.1016/j.vaccine.2023.06.039. Online ahead of print.ABSTRACTBasophil activation test (BAT) can tackle multiple mechanisms underlying acute and delayed hypersensitivity to drugs and vaccines and might complement conventional allergy diagnostics but its role in anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine-related hypersensitivity is ill-defined. Therefore, 89 patients with possible hypersensitivity (56 % with delayed mucocutaneous manifestations) to anti-SARS-CoV-2 vaccines were tested with BAT for Macrogol 3350, DMG-PEG 2000, PEG 20000, polysorba...
Source: Vaccine - June 22, 2023 Category: Allergy & Immunology Authors: Patrizia Pignatti Giuseppe Alvise Ramirez Marco Russo Paolo Marraccini Serena Nannipieri Chiara Asperti Fabrizio Della Torre Antonio Tiri Beatrice Maria Gatti Antonella Gurrado Antonio Meriggi Giovanni Benanti Maria Bernadette Cilona Paolo Pigatto Samuele Source Type: research
